You searched for "simulator"
In conversation with David Baguley
A reflective discussion with a scientist-practitioner in tinnitus David Baguley has worked in audiology at Addenbrooke’s Hospital since 1985, becoming the Consultant Clinical Scientist in 1989. In 2006, David received an International Award in Hearing from the American Academy of...
The polyp shrinker
Inflammatory markers, including T2 cells beta common (βc) cytokines IL-3, IL5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), are known to play an important role in chronic rhinosinusitis with nasal polyps (CRSwNP). CSL311, a monoclonal antibody (mAb), was developed to target human...Hearing care systems – European examples
In this article, Vice President of the European Federation of Hard of Hearing, Lidia Best, explores the drivers for improvement and change in European hearing care systems. In 2010, the European Committee for Standardization (CEN) issued the EN-15927 European Standard...ENT UK BSO Balance Course & BSO Annual Meeting
Hannah Lancer, ST8 ENT Registrar, Queen Elizabeth Hospital, West Midlands. Hosted in the recently refurbished Royal College of Surgeons of England, the popular BSO Balance Course commenced with a morning of informative talks from both national and international faculty. Delegates...Music is noise
Marshall Chasin recaps what we know acoustically about music and noise, and discusses the potentially damaging levels of music, how temporary threshold shift (TTS) is not necessarily temporary and gives us some considerations for protective devices for musicians. Most of...Targeting the microbiome in chronic rhinosinusitis
Researchers at St Paul’s Sinus Centre and UBC in Vancouver are testing a novel treatment for CRS: transferring mucus from a healthy donor into a patient’s sinuses. Chronic rhinosinusitis (CRS) is one of the most common diseases managed by otolaryngologists...
Close monitoring of patients for delayed hyponatremia post-transsphenoidal surgery
he incidence of delayed hyponatremia is 16-28% and usually accounts for unplanned readmission of the patient within 30 days after transsphenoidal surgery. One of the surrogate measures of quality of care adopted by the government and regulatory agencies is 30-day...
Tinnitus in patients on therapy with PPI and in PPI non–users
Tinnitus is a chronic and debilitating condition and approximately 10% of the population is afflicted. A myriad of pharmacological treatments for tinnitus are available but only a few controlled studies have shown positive results. The relationship between proton pump inhibitors...
